Cite

HARVARD Citation

    Carreau, C. et al. (2020). A juvenile ALS‐like phenotype dramatically improved after high‐dose riboflavin treatment. Annals of clinical and translational neurology. 7 (2), pp. 250-253. [Online]. 
  
Back to record